At 18.8x earnings with a Price/Sales of just 0.3 and Price/Book of 1.1, IMKTA screens as a statistically cheap defensive operator rather than a growth compounder. The absence of a Forward P/E and PEG Forward removes visibility into near-term earnings acceleration, and the projected EPS next year of $5.12 versus current EPS of 7.4 implies compression rather than growth. However, the Altman Z-Score of 4.7 signals very low bankruptcy risk, and a Piotroski F-Score of 8 confirms strong underlying financial quality. This is not a high-growth story; it’s a balance-sheet-stable, cash-generating grocer trading at a muted sales multiple, priced for stagnation rather than expansion.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.